Hospital
Montrose Memorial Hospital, INC
Montrose Memorial Hospital, INC was paid $4.15M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoMONTROSE MEMORIAL HOSPITAL, INC
MONTROSE, CO 81401
MONTROSE, CO 81401
33aNPI1205822186assigned 09/26/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.15M
24GClaims126,426
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#20 of 51
Median peer was paid$1.24M
This provider vs. median3.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,623 | $491K | |
| 2019 | 22,272 | $490K | |
| 2020 | 10,909 | $198K | |
| 2021 | 13,557 | $307K | |
| 2022 | 17,806 | $453K | |
| 2023 | 26,492 | $1.45M | |
| 2024incomplete | 12,767 | $768K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 11,125 | 10,348 | $1.46M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 5,726 | 4,984 | $762K |
| 96361 | Intravenous infusion, hydration; each additional hour | 9.5% | 1,168 | 1,014 | $393K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.4% | 1,936 | 1,702 | $265K |
| 80053 | Comprehensive metabolic panel | 5.5% | 19,088 | 15,133 | $228K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.9% | 4,490 | 1,598 | $119K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 25,633 | 20,068 | $100K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.0% | 3,060 | 952 | $82K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.6% | 1,867 | 1,678 | $67K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 4,582 | 4,158 | $63K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.3% | 1,868 | 1,679 | $55K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 303 | 210 | $46K |
80 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 598 | $39K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,757 | $36K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 202 | $34K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,715 | $31K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 165 | $29K |
| 97161 | <1% | 169 | $28K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,403 | $25K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 555 | $25K |
| 80061 | Lipid panel | <1% | 1,910 | $24K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 532 | $20K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 30 | $19K |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,384 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,630 | $17K |
| 64483 | <1% | 14 | $11K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 234 | $11K |
| 80305 | <1% | 788 | $10K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 336 | $10K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 154 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,213 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 703 | $9K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 68 | $9K |
| 83690 | <1% | 1,429 | $6K | |
| 88142 | <1% | 366 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 266 | $6K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 107 | $6K |
| 81001 | <1% | 1,211 | $5K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 61 | $5K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $4K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 130 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 989 | $3K |
| 97162 | <1% | 93 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 174 | $3K |
| 87081 | <1% | 232 | $2K | |
| 81003 | <1% | 625 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $2K |
| 88174 | <1% | 167 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 58 | $2K |
| 85027 | <1% | 451 | $2K | |
| 80055 | <1% | 100 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 78 | $2K |
| 87186 | <1% | 155 | $1K | |
| 87653 | <1% | 42 | $1K | |
| 84484 | <1% | 273 | $1K | |
| 82607 | <1% | 89 | $1K | |
| 87077 | <1% | 155 | $1K | |
| 87070 | <1% | 167 | $1K | |
| 84439 | <1% | 117 | $940.80 | |
| 81002 | <1% | 357 | $818.21 | |
| 73630 | <1% | 15 | $810.10 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,317 | $608.85 |
| 85651 | <1% | 147 | $510.97 | |
| 85610 | <1% | 150 | $497.20 | |
| 86803 | <1% | 57 | $473.43 | |
| 81025 | <1% | 65 | $440.10 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,284 | $438.54 |
| 82728 | <1% | 31 | $435.25 | |
| 83615 | <1% | 249 | $419.19 | |
| 86140 | <1% | 76 | $389.94 | |
| 85380 | <1% | 47 | $389.35 | |
| 83721 | <1% | 34 | $369.00 | |
| 83550 | <1% | 30 | $315.84 | |
| 84702 | <1% | 16 | $270.60 | |
| 83540 | <1% | 34 | $248.50 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 30 | $233.90 |
| 84481 | <1% | 13 | $218.50 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 18 | $155.21 |
| 86901 | <1% | 34 | $151.80 | |
| 83735 | <1% | 20 | $147.05 | |
| 86900 | <1% | 34 | $112.50 | |
| 84703 | <1% | 33 | $108.87 | |
| 82248 | <1% | 13 | $84.11 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,610 | $70.30 |
| J3490 | Unclassified drugs | <1% | 3,239 | $56.51 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,071 | $29.23 |
| 83605 | <1% | 15 | $21.36 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 44 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 83 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 17 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 21 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 255 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBEAVER, MEGAN (ANAYLST)
Parent organizationMONTROSE MEMORIAL HOSPITAL, INC
| Provider | Location | Paid |
|---|---|---|
| Montrose Memorial Hospital, INC | Montrose, CO | $4.75M |
| Alpine Women's Centre at Montrose Memorial Hospital | Montrose, CO | $250K |
| Montrose Memorial Hospital, INC | Montrose, CO | $79K |
| Montrose Regional Cancer Care | Montrose, CO | $71K |
| Montrose Memorial Hospital, INC | Montrose, CO | $40K |
| Montrose Memorial Hospital, INC | Montrose, CO | $10K |
| Montrose Memorial Hospital, INC | Montrose, CO | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.